Maharashtra, India

Maheshkumar Gadakar

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Maheshkumar Gadakar: Innovator in Pharmaceutical Chemistry

Introduction

Maheshkumar Gadakar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of biologically active molecules. With a total of three patents to his name, his work has had a considerable impact on drug development.

Latest Patents

One of his latest patents involves the synthesis of Sitagliptin. This invention relates to novel processes for the preparation of enantiomerically enriched β-amino acid derivatives, which are useful for synthesizing biologically active molecules like Sitagliptin. A key step in this process involves the resolution of the racemate with mandelic acid. Another significant patent focuses on processes suitable for the preparation of Salmeterol. This invention details the preparation of various intermediates and the final product, Salmeterol xinafoate, which is crucial for respiratory therapies.

Career Highlights

Throughout his career, Maheshkumar has worked with prominent companies in the pharmaceutical sector, including Generics UK Limited and Generics Limited. His expertise in drug synthesis and development has been instrumental in advancing pharmaceutical research.

Collaborations

He has collaborated with notable professionals in the field, including Vinayak Govind Gore and Ramakrishnan Arul. These collaborations have further enriched his research and development efforts.

Conclusion

Maheshkumar Gadakar's innovative work in pharmaceutical chemistry exemplifies the importance of research and development in creating effective medications. His contributions continue to influence the industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…